Stryker (NYSE:SYK) tapped Dr. Scott Bruder, a Becton Dickinson & Co. (NYSE:BDX) veteran, to fill its newly created chief medical & scientific officer position.
Reporting to president & CEO Kevin Lobo, Bruder will oversee Stryker’s clinical and scientific initiatives and represent the Kalamazoo, Mich.-based medical device company to trade associations and regulatory bodies, according to a press release.
Bruder was most recently BD’s CMO, following an 8-year stint at Johnson & Johnson (NYSE:JNJ). His résumé also includes stops at Anika Therapeutics and Osiris Therapeutics, according to the release.
"We are excited that Scott will be joining our executive leadership team and further broadening our clinical and scientific expertise while also strengthening our capabilities in the critical areas of evidence-based medicine," Lobo said in prepared remarks.
